June 27, 2017 | Israeli personalized diets startup DayTwo has raised $12 million in a Series A round of financing led by Johnson & Johnson Innovation. This investment brings the company’s total funding to $17 million. Founded in 2015 and led by CEO Lihi Segal, DayTwo uses individuals’ gut bacteria to create personalized nutrition. The new funds will help expand the company’s product, engineering, and data science teams in Tel Aviv and San Francisco while also supporting its research with the Mayo Clinic and other clinical partners.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments